DiscoverModPath ChatStaging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman
Staging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman

Staging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman

Update: 2024-08-21
Share

Description

Non-small cell lung carcinomas (NSCLCs) commonly present as 2 or more separate tumors. They encompass separate primary lung carcinomas (SPLCs), representing independently arising tumors, or intrapulmonary metastases (IPMs), representing intrapulmonary spread of a single tumor. In this episode, Dr. Natasha Rekhtman, from Memorial Sloan Kettering Cancer Ctr, NY provides an update on the growing applications of genomic testing as a clinically relevant benchmark for determining clonal relationships in multiple NSCLCs. She discusses the limitations of morphology-based distinction of SPLCs vs IPMs and the pivotal insights that have emerged from studying multiple NSCLCs using genomic approaches as a gold standard.

Comments 
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Staging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman

Staging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman